U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399964) titled 'Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia' on Jan. 28. Brief... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399132) titled 'Phase 1 Study of APL-10456-Vaccine' on Jan. 27. Brief Summary: AP09CP01 is a Phase 1, Rand... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400614) titled 'Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period' on Feb.... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400354) titled 'The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric C... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398677) titled 'SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to ... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400575) titled 'Anlotinib in Cross-line Treatment of NSCLC and SCLC' on Jan. 27. Brief Summary: Previous s... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398573) titled 'Comparison of Caudal and Quadratus Lumborum Blocks With Pain Monitoring in Children' on Sep... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399951) titled 'Washington University WU 409: Immune Responses to Rabies Vaccine.' on Jan. 27. Brief Summa... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401745) titled 'Occlusal Splint Combined With Granisetron Injection for Managing Myofascial Pain Related to... Read More
U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398937) titled 'Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-I... Read More